Mirum Pharmaceuticals (08D) Q3 2021 Earnings Report
1 Followers
DE:08D Q3 2021 EPS Results
- Actual EPS
- -EUR 1.38
- Consensus EPS
- -EUR 1.55
- Beat/Miss
- Beat by +EUR 0.16
- One Year Ago EPS
- -EUR 0.77
DE:08D Q3 2021 Revenue Results
- Actual Revenue
- EUR 4.46M
- Expected Revenue
- EUR 892.05K
- Beat/Miss
- Beat by +EUR 3.57M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/15/2021
- Time
- After Close
- Conference Call
- Monday, November 15, 2021
DE:08D Upcoming Earnings
Mirum Pharmaceuticals's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:08D Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | -0.55- | -0.09 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.43-0.78 | 0.04 | -1840.00% (-0.82) | |
| Aug 05, 2026 | 2026 (Q2) | -0.66-0.95 | -0.11 | -783.33% (-0.84) | |
| May 06, 2026 | 2026 (Q1) | ―-11.98 | -0.27 | -4376.67% (-11.71) | |
| Feb 25, 2026 | 2025 (Q4) | 0.05-0.09 | -0.44 | 79.59% (+0.35) | |
| Nov 04, 2025 | 2025 (Q3) | -0.120.04 | -0.27 | 116.67% (+0.31) | |
| Aug 06, 2025 | 2025 (Q2) | -0.29-0.11 | -0.46 | 76.92% (+0.36) | |
| May 07, 2025 | 2025 (Q1) | -0.29-0.27 | -0.48 | 44.44% (+0.21) | |
| Feb 26, 2025 | 2024 (Q4) | -0.23-0.44 | -0.56 | 22.22% (+0.12) | |
| Nov 12, 2024 | 2024 (Q3) | -0.40-0.27 | -0.51 | 47.37% (+0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
